Human herpes virus 6: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Treatment== :* '''Human herpesvirus 6 treatment'''<ref name="pmid25582535">{{cite journal| author=Tong LX, Worswick SD| title=Viral infections in acute graft-versus-host dis...") |
No edit summary |
||
| Line 4: | Line 4: | ||
::* Note (1): Fever & rash documented in transplant patients . | ::* Note (1): Fever & rash documented in transplant patients . | ||
::* Note (2): Reactivation in hematopoietic stem cell transplant patients | ::* Note (2): Reactivation in hematopoietic stem cell transplant patients | ||
==Reference== | |||
{{reflist|2}} | |||
Latest revision as of 19:43, 28 July 2015
Treatment
- Human herpesvirus 6 treatment[1]
- Preferred regimen: Ganciclovir, Foscarnet OR Cidofovir
- Note (1): Fever & rash documented in transplant patients .
- Note (2): Reactivation in hematopoietic stem cell transplant patients
Reference
- ↑ Tong LX, Worswick SD (2015). "Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches". J Am Acad Dermatol. 72 (4): 696–702. doi:10.1016/j.jaad.2014.12.002. PMID 25582535.